Cas:162607-16-1 5-ETHYLTHIOPHENE-2-BORONIC ACID manufacturer & supplier

Chemical Name:5-ETHYLTHIOPHENE-2-BORONIC ACID

CAS.NO:162607-16-1

Synonyms:5-ethylthiophen-2-ylboronic acid;5-ETHYLTHIOPHENYLBORONIC ACID;2-ethylthiophene-5-boronic acid;5-Ethylthiophene-2-boronic acid

Molecular Formula:C₆H₉BO₂S

Molecular Weight:156.01000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:307.948ºC at 760 mmHg

Density:1.204 g/cm3

Index of Refraction:

PSA:68.70000

Exact Mass:156.04200

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-ethylthiophen-2-ylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Ethylthiophene-2-boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-ETHYLTHIOPHENYLBORONIC ACID Use and application,2-ethylthiophene-5-boronic acid technical grade,usp/ep/jp grade.

Related News: DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation. 5-ETHYLTHIOPHENE-2-BORONIC ACID manufacturer At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 5-ETHYLTHIOPHENE-2-BORONIC ACID supplier The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 5-ETHYLTHIOPHENE-2-BORONIC ACID vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 5-ETHYLTHIOPHENE-2-BORONIC ACID factory The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.